Press release
Investigation announced for Investors who lost money with shares of Acadia Healthcare Company Inc (NASDAQ: ACHC)

An investigation for investors in Acadia Healthcare Company Inc (NASDAQ: ACHC) shares over potential securities laws violations.
Investors who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Acadia Healthcare Company Inc (NASDAQ: ACHC) concerning whether a series of statements by Acadia Healthcare Company Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Franklin, TN based Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.
Acadia Healthcare Company Inc reported that its annual Total Revenue rose from over $2.61 billion in 2022 to over $2.92 billion in 2023, and that its Net Income of $273.13 million in 2022 declined to a Net Loss of $21.66 million in 2023.
On Sunday, September 1, 2024, The New York Times published an investigative report titled "How a Leading Chain of Psychiatric Hospitals Traps Patients." The report highlighted that Acadia Healthcare Company Inc, one of the largest psychiatric hospital chains in the U.S., saw a significant increase in revenue during the pandemic-driven mental health crisis. However, the investigation revealed troubling practices, including allegations that Acadia detained patients against their will without medical necessity. In at least 12 of the 19 states where Acadia operates, numerous patients, employees, and police officers reported these unlawful detentions to authorities. In some instances, judges had to intervene to secure the release of patients.
Shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) declined from $82.41 per share on August 30, 2024, to as low as $75.46 per share on September 11, 2024.
Those who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors who lost money with shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) here
News-ID: 3658561 • Views: …
More Releases from Shareholders Foundation, Inc.

Lawsuit filed for Investors who lost money with shares of Tronox Holdings plc (N …
An investor, who purchased shares of Tronox Holdings plc (NYSE: TROX), filed a lawsuit over alleged violations of Federal Securities Laws by Tronox Holdings plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Tronox Holdings plc (NYSE: TROX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 3, 2025. NYSE: TROX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…

Investigation announced for Investors in Petco Health and Wellness Company, Inc. …
An investigation was announced for current long-term investors in shares of Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) concerning potential breaches of fiduciary duties by certain directors of Petco Health and Wellness Company, Inc.
Investors who are current long term investors in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation…

Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) …
An investigation was announced for current long-term investors in shares of RxSight, Inc. (NASDAQ: RXST) concerning potential breaches of fiduciary duties by certain directors of RxSight, Inc.
Investors who are current long term investors in RxSight, Inc. (NASDAQ: RXST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: RXST…

Tesla, Inc. (NASDAQ: TSLA) Investor Alert: Deadline in Lawsuit on October 3, 202 …
A deadline is coming up on October 3, 2025 in the lawsuit filed for certain investors of Tesla, Inc. (NASDAQ: TSLA) over alleged securities laws violations by Tesla, Inc.
Investors who purchased shares of Tesla, Inc. (NASDAQ: TSLA) have certain options and there are strict and short deadlines running. Deadline: October 3, 2025. Tesla, Inc. (NASDAQ: TSLA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Acadia
Navigating the Future: Japan Pharmaceutical Manufacturing Market | Abbott Labora …
Astute Analytica, a leading provider of market research and analysis, released its highly anticipated Market Analysis Report on the Japan Pharmaceutical Manufacturing Market. This comprehensive report aims to equip businesses with invaluable insights and data, enabling them to make informed decisions and stay one step ahead of the competition.
Access the Comprehensive PDF Market Research Analysis Report Here: https://www.astuteanalytica.com/request-sample/japan-pharmaceutical-manufacturing-market
Japan pharmaceutical manufacturing market was valued at US$ 31.74 billion in 2022…
Acadia Healthcare Company Inc (NASDAQ: ACHC) Investor Alert: Update in Lawsuit
An update was announced in the lawsuit that was filed on behalf of certain investors shares of Acadia Healthcare Company Inc (NASDAQ: ACHC)in over alleged violations of Federal Securities Laws by Acadia Healthcare Company Inc.
Investors who purchased shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On October 02, 2023, a lawsuit was filed in…
Behavioral Health Market May See Big Move | Acadia Healthcare, Ascension Seton, …
Behavioral Health Market is latest research study released by AMA Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Behavioral Health Market. Some of the key players profiled in the study are Acadia Healthcare (United States), CareTech Holdings (United Kingdom), The MENTOR Network…
Glaucoma Pharmaceuticals Market to Witness Huge Growth by 2027 | Allergan, Merck …
The Latest survey report on Glaucoma Pharmaceuticals Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Glaucoma Pharmaceuticals organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Acadia Pharmaceuticals Inc., Allergan Inc., Inotek Pharmaceuticals Corporation, Merck & Co. Inc., Santen…
Investigation announced for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: AC …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of ACADIA Pharmaceuticals Inc..
Investors who are current long term investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: ACAD stocks follows a lawsuit filed against ACADIA…
Lawsuit filed for Investors in shares of ACADIA Pharmaceuticals Inc. (NASDAQ: AC …
An investor, who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), filed a lawsuit over alleged violations of Federal Securities Laws by ACADIA Pharmaceuticals Inc.
Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have certain options and for certain investors are short and strict deadlines running. Deadline: June 18, 2021. NASDAQ: ACAD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Diego, CA based…